![](/img/cover-not-exists.png)
PD.18 Can we prioritize treatment modalities for oropharyngeal cancer based on costs of primary treatment, relapse, and grade III/IV complications?
M. van Agthoven, W.M. Nijdam, P.C. Levendag, I. Noever, C.A. Uyl-de GrootVolume:
1
Year:
2005
Language:
english
DOI:
10.1016/s1744-7895(05)80142-7
File:
PDF, 128 KB
english, 2005